02.10.2014 Views

NIS - libdoc.who.int - World Health Organization

NIS - libdoc.who.int - World Health Organization

NIS - libdoc.who.int - World Health Organization

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Styli cum stigmatis Zeae maydis<br />

min/100 g bw; p < 0.05) and the Na + filtered load (41.9–34.3, p < 0.05) decreased,<br />

and creatinine and Li clearances and Na + excretion were unchanged,<br />

while K + excretion (0.10–0.22 µEq/min/100 g bw; p < 0.001) increased.<br />

Thus, at a water-loading of 2.5 ml/100 g bw, the extract increased diuresis at<br />

a dose of 500 mg/kg, and increased excretion of K + at doses of 350 and<br />

500 mg/kg. At a water-loading of 5 ml/100 g bw, excretion of K + increased at<br />

a dose of 500 mg/kg, but glomerular filtration decreased (64).<br />

Prevention of diabetic complications<br />

The aldehyde group of reducing sugar and amino residues in protein react<br />

and result in the formation of aggregates (advanced glycation end-products)<br />

such as N-ε-(carboxymethyl) lysine. Formation of these aggregates in the<br />

human body through glycation is associated with the induction of diabetic<br />

complications. Accumulation of N-ε-(carboxymethyl) lysine in the kidneys<br />

of subjects with diabetes has been reported. The inhibition of N-ε-<br />

(carboxymethyl) lysine accumulation by the flavone C-glucoside, chrysoeriol<br />

6-C-β-fucopyranoside, isolated from the style of Zea mays, was calculated<br />

to be 80.7% (46). The same glycation inhibiting action was later shown for<br />

the corresponding 6-boivinoside. Similar derivatives of chrysoeriol, but with<br />

one more sugar attached, were inactive. Of the purines and pyrimidines present<br />

in Zea mays, only guanosine was found to be a glycation inhibitor (65).<br />

The efficacy of a water extract of styles of Zea mays on diabetic nephropathy<br />

evoked by <strong>int</strong>ravenous injection of streptozocin (40 mg/kg) was<br />

investigated in rats randomly allocated either to a control group (non-diabetic<br />

rats, n = 5), a non-treated group of diabetic rats (n = 9), or a group of<br />

treated diabetic rats (n = 8). The treated groups were given tap water containing<br />

an extract of dry styles at a concentration of 0.15% (w/v) (about<br />

0.2 g/day), while the animals in the control and non-treated groups were<br />

given ordinary tap water. The rats were allowed free access to their water<br />

for 12 weeks. At 12 weeks, urine was collected for 24 hours using a metabolic<br />

cage, followed by the collection of a blood sample and a kidney sample<br />

after killing the animals. Plasma glucose, haemoglobin, fructosamine,<br />

creatinine, urinary creatinine, urinary albumin excretion and other clinical<br />

parameters were also measured. Creatinine clearance was calculated per<br />

100 g of body weight. The difference in body weight observed between the<br />

non-treated diabetic rats and the control rats was significant (p < 0.01). The<br />

plasma glucose levels in the non-treated diabetic rats were significantly<br />

higher than in the control animals (p < 0.01); however, there was no difference<br />

in the plasma glucose, fructosamine or haemoglobin levels between<br />

treated diabetic rats and non-treated diabetic rats. The ratios of kidney<br />

weight to body weight were significantly higher in non-treated diabetic rats<br />

429

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!